Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Avricore Health Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Str8Shooter88on Apr 27, 2016 2:02pm
129 Views
Post# 24816168

RE:RE:RE:Not sure what we can complain

RE:RE:RE:Not sure what we can complainQ1 financials are out already...incase you hadn't noticed. Sales have been proven. Look it up on Sedar and compare Q1 with Q4 2015. Things are already compounding. 

DoubleDown123 wrote:


As far as I'm concerned, last quarters financials are meaningless. Giving away free samples is pretty easy. Net Sales of only $150K. I understand it must be done to make a name for youself in the industry, but the success of this company will lie in future earnings reports. Hopefully Q1 financials show actual sales, where pharmacies are paying full pop. I sold my 35,000 share position at 0.51 because it was plain to see Q4 sales would suck as they barely had a sales staff at that point. On the sidelines until I see Q1 numbers with actual real sales growth. Anxious to get back in, but don't see a point in holding until meaningful sales are proven.



Bullboard Posts
Dealroom for high-potential pre-IPO opportunities